Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus

被引：0
|
作者：
Yanli Zeng
Qiaoduan Lin
Liang Yu
Xuelian Wang
Yiqiang Lin
Yan Zhang
Shuidi Yan
Xinxin Lu
Yijing Li
Weibin Li
Yun Xiao
机构：
[1] Xiamen University,Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine
[2] Zhongshan Hospital of Xiamen University,Ultrasonography Department
[3] Zhongshan Hospital of Xiamen University,Department of Obstetrics and Gynecology
[4] The 900Th Hospital of Joint Logistic Support Force,Institute for Laboratory Medicine
来源：
BMC Immunology | / 22卷
关键词：
CXC ligand 1 (CXCL1); Growth-related oncogene-α (GRO-α); High-avidity IgG ANAs (HA IgG ANAs); Systemic lupus erythematosus (SLE); Lupus nephritis (LN);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus
    Zhang, Xiaomin
    Liu, Chang
    Yang, Jieli
    Ren, Hefei
    Zhang, Jiafeng
    Chen, Sai
    Ren, Jigang
    Zhou, Lin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [32] Chemokine expression in systemic lupus erythematosus
    McCarthy, E. M.
    Lee, R. Z.
    Gabhann, J. Ni
    Smith, S.
    Cunnane, G.
    Doran, M. F.
    Howard, D.
    O'Connell, P.
    Jefferies, C. A.
    Kearns, G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S112 - S112
  • [33] Chemokine Expression In Systemic Lupus Erythematosus
    McCarthy, Eoghan M.
    Gabhann, Joan Ni
    Smith, Siobhan
    Lee, Ruth
    Cunnane, Gaye
    Doran, Michele
    Howard, Donough G.
    O'Connell, Paul G.
    Kearns, Grainne M.
    Jefferies, Caroline
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S796 - S796
  • [34] SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
    Yang, Chi-Hui
    Wang, Xin-Yi
    Zhang, Yi-Hui
    Ding, Ning
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [35] Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: A potential marker for disease activity
    Li, JS
    Liu, MF
    Lei, HY
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 79 (03): : 211 - 216
  • [36] Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
    Han, Ke-qi
    Han, Hui
    He, Xue-qun
    Wang, Lei
    Guo, Xiao-dong
    Zhang, Xue-ming
    Chen, Jie
    Zhu, Quan-gang
    Nian, Hua
    Zhai, Xiao-feng
    Jiang, Ma-wei
    CANCER MEDICINE, 2016, 5 (10): : 2861 - 2872
  • [37] Headache in systemic lupus and systemic lupus erythematosus disease activity.
    Hansen, H
    Sibbitt, WL
    Bankhurst, AD
    Brandt, J
    Wong, C
    Johnson, C
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S153 - S153
  • [38] Chemokines and chemokine receptors: Potential therapeutic targets in systemic lupus erythematosus
    Duan, Lishuang
    Yao, Yongxing
    Kong, Haiying
    Zhou, Yanfeng
    Cui, Dawei
    CYTOKINE, 2024, 184
  • [39] Targeting Fli-1 and chemokine axis CXCL10/CXCL13/CXCR3 in systemic lupus erythematosus and lupus nephritis
    Zhu, Da-Yong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (02)
  • [40] Usefulness in daily practice of the Systemic Lupus Erythematosus Disease Activity Index 2000 scale and the Systemic Lupus Erythematosus Disease Activity Score index for assessing the activity of systemic lupus erythematosus
    Suszek, Dorota
    Dubaj, Maciej
    Bigosinski, Karol
    Dembowska, Aleksandra
    Kaniewski, Marcin
    Sielwanowska, Wiktoria
    Skierkowski, Bartosz
    Dzikowska, Izabela
    Sieczka, Julia
    Majdan, Maria
    REUMATOLOGIA, 2024, 62 (03): : 187 - 195
12345